Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

The COVID-19 pandemic affected hair restoration practices in 2022.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

Topical Minoxidil is effective for hair loss after COVID-19.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.